Financial Performance - The company's 2025 revenue reached $9.8 billion[5], demonstrating a 2.2% year-over-year increase[44] - The three-year Compound Annual Growth Rate (CAGR) for revenue is 15.8%[5] - Adjusted Free Cash Flow for FY 2025 was $626 million[5] - The company anticipates revenue between $10.04 billion and $10.18 billion for FY 2026[44] - The company returned over $258 million to shareholders through share repurchases and dividends in FY 2025[43] Client Base and Services - The company serves over 2,000 clients, including over 160 Fortune Global 500 clients[5] - The company's client base includes 8 of the top 10 Fintech companies and 10 of the top 10 global automotive companies[18] - The company offers a broad portfolio of services including Strategy & Design, Data & Analytics, and Enterprise Technology[13, 14, 16] AI and Operational Improvements - The company's AI solutions are deployed across 1,000+ clients and 400,000+ desktops[35] - An energy client case study showed a 16.5% improvement in first contact resolution after implementing the company's solutions[26] - A consumer goods case study showed a 1.8% increase in Customer Satisfaction (CSAT) and a 7% improvement in Average Handle Time (AHT)[27]

Company Presentation January 2026 Disclaimer All statements in this presentation other than statements of historical fact are forward-looking statements, which are subject to a number of risks, uncertainties, and assumptions that are difficult to predict and are based upon assumptions as to future events that may not prove accurate. Certain such forward-looking statements can be identified by the use of forward-looking terminology such as "believe", "may", "will", "should", "would be", "expect" or "anticipa ...

Needham Growth Conference January 13, 2026 Nasdaq: ATRO Peter J. Gundermann, Chairman, President & CEO Nancy L. Hedges, Vice President & CFO astronics.com Safe Harbor Statement This presentation contains forward-looking statements as defined by the Securities Exchange Act of 1934. One can identify these forward-looking statements by the use of the words "expect," "anticipate," "plan," "may," "will," "estimate," "feeling" or other similar expressions and include all statements with regard to the Company's pr ...

Investor Presentation January 2026 Cautionary Notes Forward Looking Statements: Certain statements in this presentation may be considered forward-looking statements, including statements with respect to the Company's outlook and expectations, including expectations with respect to a plan to deliver 108Q chiplet-based system at 99.5% median 2Q gate fidelity around the end of Q1 2026 and to reach 1,000+Q at 99.9% median 2Q median fidelity at <50 ns gate speed in 3-5 years to enable quantum advantage; an antic ...

Investor Presentation January 2026 This presentation contains forward-looking statements within the meaning of the Private Securities litigation Reform Act of 1995. Statements in this presentation that are not statements of historical fact are considered forward-looking statements, which are usually identified by the use of words such as "anticipates," believes," "continues," "could," "estimates," "expects," "intends," "may," "plans," "potential," "predicts," " projects," "seeks," "should," "will," "forecas ...

Transformative immunomodulating medicines for patients January 2026 To add/change the picture: • Click on the image and press BACKSPACE or DELETE on the keyboard > Click on the icon at the centre of the placeholder > Select the chosen image • To adjust the crop, right-click on the image > Crop • If for any reason the image placeholder loses the rounded shape, click on Reset button in the Home tab at the top. To add/change the picture: • Click on the image and press BACKSPACE or DELETE on the keyboard > Clic ...

J.P. Morgan Healthcare Conference 2026 Hikaru Samejima Chief Executive Officer Terumo Corporation Jan. 12, 2026 Forward-Looking Statements and Use of Document Among the information that Terumo discloses, the forward-looking statements including financial projections are based upon our assumptions using information available to us at the time and are not intended to be guarantees of future events or performance. Accordingly, it should be noted that actual results may differ from those forecasts or projection ...

J.P. MORGAN 2026 HEALTHCARE CONFERENCE JANUARY 12, 2026 Building Next-Generation Oncology Franchises Michael M. Morrissey, Ph.D. President and CEO Safe Harbor Statement This presentation, including any oral presentation accompanying it, contains forward-looking statements, including, without limitation, statements related to: Exelixis' strategy to build franchises in key solid tumors; Exelixis' goal to become a leader in oncology R&D and a top 5 solid tumor oncology company, with multiple blockbuster produc ...

Investor Presentation January 2026 Forward Looking Statements This presentation contains forward -looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 , Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward - looking statements include any statements about the Company's business, financial condition, operating results, plans, object ive s, expectations and intentions, expansion plans, estimates of our total addressable market, our ability to ...

NVIDIA Healthcare and Life Sciences Kimberly Powell, VP of Healthcare and Lifesciences January 12, 2026 Except for the historical information contained herein, certain matters in this presentation including, but not limited to, statements as to: expectations with respect to the benefits, impact, performance, and availability of NVIDIA's products, services and technologies; expectations with respect to NVIDIA's third-party arrangements, including with its collaborators and partners; expectations with respect ...